ClinicalTrials.Veeva

Menu

Adverse Effects of Ivermectin Used in Egypt During COVID-19

M

Menoufia University

Status

Unknown

Conditions

Drug Side Effect
Covid19
Ivermectin Poisoning
Drug Toxicity

Treatments

Drug: Ivermectin

Study type

Observational

Funder types

Other

Identifiers

NCT04747678
ahmed19782020

Details and patient eligibility

About

retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

Full description

ivermectin was used in Egypt during the pandemic of covid-19 and it was registered in the MOH protocol that has been published in November 2020 the study will document the adverse effects of many patients used ivermectin as aprophylaxis and as a treatment with multiple dose regimens

Enrollment

200 estimated patients

Sex

All

Ages

16 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all people used ivermectin as a treatment or as a prophylactic in covid 19 pandemic in egypt with explained dose

Exclusion criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems